Skip Navigation

European Journal of Echocardiography 2006 7(4):263; doi:10.1016/j.euje.2006.03.010
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Collins, N. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Collins, N. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2006, The European Society of Cardiology

Reply to the letter to the editor

Nicholas John Collins*

Cardiovascular Unit, John Hunter Hospital, Lookout Rd, New Lambton, NSW 2305, Australia

Received 19 March 2006; accepted after revision 19 March 2006.

* Tel.: +1 416 726 9452. nandl_collins@yahoo.com.au

The first 10% of the full text of this article appears below.

Dr Callejas Rubio contends that the prevalence of mild pulmonary arterial hypertension (PAH) in patients with autoimmune disease (PAH) is excessively high based on the parameters used in our assessment.

Assessment of pulmonary artery pressure (PAP) remains an emerging utility . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?